| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/08/2007 | US20070054888 Novel substituted diamine derivatives useful as motilin agonists |
| 03/08/2007 | CA2620818A1 Amide derivatives as rock inhibitors |
| 03/08/2007 | CA2620631A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 03/08/2007 | CA2620600A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/08/2007 | CA2617495A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/08/2007 | CA2602442A1 Ep2 receptor agonists for treating glaucoma |
| 03/07/2007 | EP1760073A1 Sulfonamide compound |
| 03/07/2007 | EP1760072A1 1,3-diaminobenzene derivatives and colorants comprising these compounds |
| 03/07/2007 | EP1759713A2 Lock and key micelles |
| 03/07/2007 | EP1758896A1 Pyridinyl-isoxazoles and their use as herbicides |
| 03/07/2007 | EP1758862A1 Aminopyridine derivatives as selective dopamine d3 agonists |
| 03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
| 03/07/2007 | EP1758860A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 03/07/2007 | EP1758859A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/07/2007 | EP1758853A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 03/07/2007 | EP1758847A1 Inhibitors of histone deacetylase |
| 03/07/2007 | EP1758664A2 Process employing controlled crystallization in forming crystals of a pharmaceutical |
| 03/07/2007 | EP1620404B1 Novel process for the preparation of 2-aminomethylpyridine derivatives |
| 03/07/2007 | CN1926135A Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 03/07/2007 | CN1926108A Non-nucleotide reverse transcriptase inhibitors |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1926094A Amide derivatives, process for production of the same, and method for application thereof as insecticide |
| 03/07/2007 | CN1926082A Compound and organic electroluminescent element using the same |
| 03/07/2007 | CN1925862A Treatment of diseases associated with the EGR-1 enhancer element |
| 03/07/2007 | CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1303090C Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases |
| 03/07/2007 | CN1303080C Nolatrexed hydrochloride synthesis process |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1303071C Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 03/07/2007 | CN1303063C Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
| 03/07/2007 | CN1303043C Process for producing biaryl compound |
| 03/06/2007 | US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 03/06/2007 | US7186839 Extraction uisng aqueous solution containing metal compound |
| 03/06/2007 | US7186835 Composition comprising amino-imine compounds |
| 03/06/2007 | US7186834 Substituted iminoazines |
| 03/06/2007 | US7186786 Use of dithioester or trithiocarbonate chain transfer agents in Reversible addition fragmentation chain transfer (RAFT) polymerization to make low polydispersity acrylamide polymers |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186726 Preferentially substituted calcium channel blockers |
| 03/06/2007 | US7186725 Anti-inflammatory compositions and methods |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186722 active against sensitive and resistant species and against all development stages |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | CA2292895C Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2007 | CA2211048C Method for preparing pyridine-2,3-dicarboxylic acid esters |
| 03/06/2007 | CA2200898C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007024954A1 Chemical compounds |
| 03/01/2007 | WO2007024922A1 Immunosuppressant compounds and compositions |
| 03/01/2007 | WO2007024860A2 Sulfonamides |
| 03/01/2007 | WO2007024833A1 Anthranilamides for controlling invertebrate pests |
| 03/01/2007 | WO2007024754A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023768A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 03/01/2007 | WO2007023381A1 Methods for the preparation of hcv polymerase inhibitors |
| 03/01/2007 | WO2007023295A2 Use of grinding in chemical synthesis |
| 03/01/2007 | WO2007022964A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 03/01/2007 | WO2006138510B1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/01/2007 | WO2006119713A3 Antineoplastic compounds and pharmaceutical compositions thereof |
| 03/01/2007 | WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/01/2007 | US20070049625 3-{[(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid; post-surgical and post-laser trabeculectomy ocular hypertensive episodes, presurgical adjuncts |
| 03/01/2007 | US20070049624 a mixture of 1-(4-hydroxyphenyl)-5-methylpyridin-2-one and pharmaceutically-acceptable excipients, used foro the treatment of liver fibrosis |
| 03/01/2007 | US20070049595 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; osteoporosis |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2619366A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseases |
| 03/01/2007 | CA2619101A1 Immunosuppressant compounds and compositions |
| 03/01/2007 | CA2602969A1 Sulfonamides |
| 02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 02/28/2007 | EP1757593A1 Therapeutic agent for nonviral hepatitis |
| 02/28/2007 | EP1757586A1 Polysbustituirte 1,1-pyridinylaminocyclopropanamin derivate, verfahren zu deren herstellung und diese enthaltende pharmatuetische zusammensetzung |
| 02/28/2007 | EP1756119A1 Collection of traceable compounds and uses thereof |
| 02/28/2007 | EP1756103A2 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
| 02/28/2007 | EP1756099A1 Synthesis of antidiabetic rosiglitazone derivatives |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756062A1 Compounds and compositions as ppar modulators |
| 02/28/2007 | EP1756061A1 Therapeutic compounds: pyridine n oxide scaffold |
| 02/28/2007 | EP1756060A1 Therapeutic compounds: pyridine as scaffold |
| 02/28/2007 | EP1756059A1 Process for the production of cyclic diketones |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756043A1 Ortho substituted aryl or heteroaryl amide compounds |
| 02/28/2007 | EP1756042A1 Substituted methyl aryl or heteroaryl amide compounds |
| 02/28/2007 | EP1756029A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles |
| 02/28/2007 | EP1756023A1 Molecularly imprinted polymers selective for nitrosamines and methods of using the same |
| 02/28/2007 | EP1755596A2 Process for preparing atazanavir bisulfate and novel forms |
| 02/28/2007 | EP1755586A2 Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors |
| 02/28/2007 | EP1755572A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
| 02/28/2007 | EP1615629A4 Peptide deformylase inhibitors |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1379505B1 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |